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Abstract
Background: To know the epidemiology (prevalence, incidence, progression and morbidity and mortality associated)
of peripheral artery disease in general population and the factors associated with this progression is essential to know
the evolution of atherosclerosis and develop preventive strategies. The aim of the study was to determine the incidence
of PAD after 5 years of follow-up population-based cohort ARTPER, and the evolution of Ankle brachial Index (ABI) in
this period.
Methods: Peripheral artery disease incidence analysis after 5 years of follow-up of 3786 subjects > 50 years old.
Peripheral artery disease incident when the second cross section Ankle brachial Index was <0.9 in any of the
lower limbs, with normal baseline (0.9 to 1.4).
Results: Between 2012 and 2013 2762 individuals (77 % participation) were re-examined . Finally analyzed 2256
subjects (after excluding pathological Ankle brachial Index) followed for 4.9 years (range 3.8 to 5.8 years), totalling
11,106 person-years. Peripheral artery disease 95 new cases were detected, representing an incidence of 4.3 % at
5 years and 8.6 per 1000 person-years (95 % CI 6.9 to 10.5) being higher in men (10.2, 95 % CI 7.4 to 13.5) than in
women (7.5, 95 % CI 5.5 to 9.9). Linear correlation between the baseline Ankle brachial Index and the second
cross section was low (r = 0.23).
Conclusions: The incidence of peripheral artery disease in ARTPER cohort was 8.6 cases per 1000 person-years,
being higher in men, especially <65 years. The correlation between two measures Ankle brachial Index after
5 years of follow-up was low. One might consider whether Ankle brachial Index repeated measures could
improve the correlation.
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Background
Atherosclerosis is currently considered to be a systemic,
chronic and progressive illness, having complex patho-
genic mechanisms. It occurs in coronary heart disease,
cerebrovascular disease, erectile dysfunction and periph-
eral artery disease (PAD).
The prevalence of PAD of the lower extremities, par-
ticularly in the asymptomatic forms, is high. [1] Globally
speaking, 202 million people have PAD. In Europe, there
has been an increased prevalence of this disease by
13.8 % over the past decade [1]. In countries having low
cardiovascular risk such as Spain, the prevalence is situ-
ated between 3.7 and 7.6 % [2–5].
PAD is a major cause of decreased quality of life, lower
life expectancy and is a major cause of morbidity and mor-
tality [6–10]. With regard to quality of life, 10–20 % of the
subjects with PAD have intermittent claudication [6, 7]
and up to 50 % may have atypical symptoms in the lower
extremities [7]. In addition, PAD triples the risk of mortal-
ity and major cardiovascular events including myocardial
infarction and stroke [8–10].
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Several population-based studies have evaluated the as-
sociation between the incidence of PAD and the risk fac-
tors associated with the progression of this disease [11, 12].
However, the incidence of PAD in Spain has only been
studied in selected populations and not in the general
population [13, 14]. As for the progression of PAD, there
is little agreement among the different studies published
to date. Some authors consider the progression of the dis-
ease to be demonstrated by a change in ABI from normal
to pathological (<0.9 or ≥1.4) [15, 16]; while other authors
consider a specific decrease in ABI values [1, 16–18] and
still others consider the progression of PAD to occur only
when there are vascular events. As for the evolution of
ABI values over time, while some authors have described
decreases in said values [19–22] while other researchers
have reported increases in these values [15, 17, 18].
A decrease in ABI values along follow-up period has
also been associated with an increase in both cardiovas-
cular morbidity and mortality from other causes (cardio-
vascular and not cardiovascular) [17].
In subjects with high vascular risk, the determination of
ABI may provide relevant information on the presence of
sub-clinical arteriosclerosis and future vascular events.
From the perspective of primary prevention, the develop-
ment of strategies to allow for the identification of sub-
clinical atheromatous is needed. One strategy to achieve
this may be to detect PAD in the lower extremities using
the ABI. REASON is a validated pre-screening test used in
our country to determine asymptomatic candidates based
on ABI [23].
It is fundamental to understand the epidemiology of
PAD in the general Spanish population as well as the fac-
tors associated with its progression in order to evaluate
the evolution of arteriosclerosis and develop preventative
strategies. The main objective of this study was to deter-
mine the incidence of PAD after 5 years of follow-up of
the ARTPER cohort, as well as the evolution of ABI over
the same study period.
Methods
ARTPER is a population cohort of 3786 subjects over the
age of 50, recruited between 2006 and 2008 from 24 Pri-
mary Health Centres of the metropolitan Barcelona area
and Barcelonés Nord-Maresme (approximately 600,000
inhabitants). Follow-up was conducted via telephone and
clinical history reviews were made every 6 months from
their creation until 2012 (date when the cohort was re-
examined in situ). A description of the study methodology
was previously published [4, 24].
Two health care professionals trained in the procedure
performed the ABI measurements in a standardized man-
ner [6]. An ABI < 0.9 was considered to be indicative of
PAD, while an ABI ≥ 1.4 represents arterial calcification.
Definition of peripheral artery disease incidence
A decrease in abnormal ABI values (<0.9) in either of
the two lower extremities in the second ABI determin-
ation at 5 years compared to normal baseline ABI (from
0.9 to 1.4) was considered to indicative a PAD event.
Progression of the illness
The progression of PAD is considered on finding a de-
crease >10 % in the minimum ABI values of either of
the extremities over time compared to baseline.
Statistical methods
All of the variables were subject to a thorough quality con-
trol process. Continuous variables are described as mean
and standard deviation while the categorical variables are
expressed as frequency and percentage. Comparisons of
continual variables were made with the Student’s t tests and
categorical variables were compared with the Chi-square
tests. The following dependent variables were studied as
well as their association with other variables: 1.- incidence
of PAD, using Cox regression models to determine the as-
sociation with potentially associated factors, adjusted by
age, gender and baseline ABI; 2.- disease progression, using
logistic regression models to determine the association with
potentially associated factors, adjusted by age and gender.
In all cases, the possibility of creating transformations or
clusters to improve the fit of the model was analysed. For
the two dependent variables, a multivariate model was
developed which initially included all of the variables with
p < 0.2 in the bivariate models adjusted by age and gender
(and baseline ABI in the Cox models). The models having
the best fit to the data were determined using the Akaike
criterion, residual behaviour, and Harrell’s C index and pro-
portionality (Cox models) and Hosmer-Lemeshow (logistics
models), considering their interpretability and biological
plausibility. Some variables that were significant (p < 0.05)
in the bivariate models were no longer significant when ad-
justed for by others. In the final multivariate models, only
variables with p < 0.05 were included. In the Cox models,
the baseline ABI was adjusted for, even though this is not
revealed in the tables. All comparisons were bilateral and
the confidence interval was 95 %. The Stata 13 statistical
package was used.
Ethics
This study was approved by the Ethical Committee of
Primary Health Care. All participants signed informed
consent to participate.
Results
A total of 3786 patients >55 years of age were recruited
from March 2011 to September of 2012. Of these 2762 in-
dividuals were evaluated in the second ABI measurements
(77 %). On comparing the study participants (n = 2762)
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with the non-participants (n = 1024) several differences
were found with regard to age (64 vs 68 years, p < 0.001),
female gender (55 % vs 51 %, p = 0.013), smoking habit
(56 % non-smokers vs 52 %, p = 0.025), physical exercise
(5734 METS in 14 days vs 4743, p < 0.001), hypertension
(54 % vs 53 %, p < 0.001), hypercholesterolemia (49 % vs
45 %, p = 0.009), diabetes (15 % vs 19 %, p = 0.009), cardio-
vascular risk (REGICOR 5.8 % vs 6.6 %, p < 0.001). No dif-
ferences were found in relation to the body mass index
(29 in both groups) and clinical history of intermittent
claudication (10 % in both groups). The incidence of PAD
was analysed in 2256 subjects with normal ABI were
included (0.90– 1.40). Patients with a baseline ABI <0.9
(n = 180) and ≥ 1.40 (n = 163) and those showing calcifica-
tion in the follow-up (n = 153) or who were unable to
undergo the second ABI measurement (n = 10) were ex-
cluded (Fig. 1). The baseline characteristics of the 2256
subjects analysed are shown in Table 1. The study partici-
pants were followed for 4.9 years (range: 3.8–5.8 years),
with a total of 11,106 individuals-year. The mean baseline
ABI was 1.093, being 1.099 at follow-up. Ninety-five new
cases of PAD were identified, representing an incidence of
PAD of 4.3 % at 5 years or of 8.6 per 1000 individuals-year
(confidence interval (CI) of 95 % 6.9–10.5), being higher
in men (10.2, CI 95 % 7.4–13.5) than in women (7.5, CI
95 % 5.5–9.9) (Table 2). The incidence of PAD in subjects
< 65 years of age at follow-up was double for men (9.9 per
1000 individuals-year) as compared to women (4.8 per
1000 individuals-year), while in those > 75 years of age,
the incidences was similar, at around 12.5 cases per
1000 individuals-year. Overall incidence of PAD was
8.8 per 1000 individuals-year (CI 95 % 6.8–10.8) after
direct standardization by the age (>50) and sex European
Union structure [25].
In healthy patients (normal baseline ABI) a decrease
in ABI >10 % was observed in 15 % (n = 326), with an
increase > 10 % being found in 24 % of the participants
(n = 510).
In patients presenting a PAD event, the baseline ABI
was 1.01, decreasing to 0.80 at follow-up. At follow-up a
decrease in ABI >10 % was observed in 83 % of the popu-
lation with PAD (n = 79). The linear correlation between
baseline ABI and that at follow-up was low (r = 0.23).
Only 1 out of every 4 patients with PAD revealed clin-
ical histories of intermittent claudication, with the re-
mainder being asymptomatic.
The incidence of PAD was significantly associated with
male gender, age, smoking habit, major physical activity
limitations, arterial hypertension, diabetes and low HDL
cholesterol in models adjusted for age, gender and base-
line ABI (Table 3).
Using a model adjusting for the baseline ABI, the fol-
lowing variables were significantly associated with the in-
cidence of PAD: Age (hazard ratio (HR) 1.04 per year),
smoking (HR 3.49), major physical activity limitation (HR
2.36) and low HDL cholesterol levels (HR 1.68) (Table 4).
Fig. 1 Flow Chart ARTPER cohort
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Table 1 Baseline characteristics of the sample, according to incidence of peripheral artery disease (PAD)
Without PAD With PAD Total
n = 2161 n = 95 na = 2256
n % n % n % p
Men 887 41 % 46 48 % 933 41 % 0.153
Age (mean, SD) 63 7.7 66 9.0 63 7.8 0.000
Age category 0.023
49–64 1337 62 % 46 48 % 1383 61 %
65–69 376 17 % 20 21 % 396 18 %
70–86 448 21 % 29 31 % 477 21 %
Education level 0.332
Illiterate 97 5 % 7 8 % 104 5 %
Primary education 1482 72 % 63 69 % 1545 72 %
Secondary education 408 20 % 20 22 % 428 20 %
University 73 4 % 1 1 % 74 3 %
Smoking habit 0.000
Never smoker 1285 59 % 37 39 % 1322 58.6 %
Former smoker 532 25 % 31 33 % 563 25.0 %
Current smoker 344 16 % 27 28 % 371 16.4 %
Physical activity in leisure timeb (mean, SD) 5.8 3.5 4.7 3.7 5.8 3.6 0.009
Physical activity limitations 0.000
None 933 44 % 21 22 % 954 43 %
Moderate 1052 49 % 56 60 % 1108 50 %
Can only do light activities 142 7 % 13 14 % 155 7 %
Any activity causes breathlessness 15 1 % 4 4 % 19 1 %
Body mass index (Kg/m2) (mean, SD) 29 4.5 30 5.6 29 4.6 0.091
Central obesityc 1283 60 % 63 66 % 1346 60 % 0.196
Morbidity (clinical record)
Hypertension 891 42 % 57 62 % 948 43 % 0.000
Hypercholesterolemia 1015 48 % 50 53 % 1065 48 % 0.334
Diabetes 268 12 % 21 22 % 289 13 % 0.006
High LDL (>130 mg/dl) 1225 57 % 53 56 % 1278 57 % 0.783
Low HDL (<40 mg/dl men, <50 mg/dl women) 410 19 % 30 32 % 440 20 % 0.002
High triglycerides (>150 mg/dl) 506 24 % 27 28 % 533 24 % 0.286
Atherogenic dyslipidaemia 199 9 % 11 12 % 210 9 % 0.437
REGICOR scored 0.000
≤ 5 % 1253 64 % 32 43 % 1285 64 %
5–10 % 524 27 % 27 36 % 551 27 %
> 10 % 166 9 % 16 21 % 182 9 %
Framingham scored 0.000
≤ 10 % 940 48 % 24 32 % 964 48 %
10–20 % 669 34 % 24 32 % 693 34 %
> 20 % 334 17 % 27 36 % 361 18 %
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The multivariate model showed the risk factors posi-
tively and significantly associated with PAD progression
(decrease in ABI > 10 %) to be similar to those associated
with the incidence of PAD, with the exception of HDL
cholesterol and the appearance of a protective effect for
the level of education (Table 5).
Discussion
To our knowledge, ARTPER is the first population study
carried out in Spain to evaluate the incidence of PAD after
5 years of follow-up. The incidence of PAD was 8.6 per
1000 individuals-year, being higher in men than in women,
in both the symptomatic and asymptomatic disease.
Previous examinations of incidence carried out in
Spain were not population-based studies [13, 14], and
obtained incidences between 14.3 (Lahoz) [13] and 23.8
(Merino) [14] per 1000 individuals-year with 4 and
5 years of follow-up respectively. The study conducted
by Lahoz et al [13] was carried out on volunteer subjects
of both genders (35.9 % male) between 60 and 79 years
of age, recruited from one primary health care centre.
The greater incidence of PAD found in this study may
be explained by the higher age of participants, since
PAD increases in both genders with age [4, 14]. The
higher incidence found in the study by Merino et al [14]
performed in men between the ages of 55 and 74 attend-
ing four primary health centres and selected by simple
randomization, may be due to the high prevalence of
smokers found in this population (48.9 % ex-smokers
and 27.8 % active smokers). In addition, the study sub-
jects were exclusively males and patients rather than a
general population.
The incidence of PAD in our study was also lower
than that found in the majority of European and North
American studies [15, 16, 19, 26, 27] which range be-
tween five and 44 per 1000 individuals-year.
In the Multi-Ethnic Study of Atherosclerosis (MESA)
[15], an incidence of 5.0 per 1000 individuals-year was
found in subjects with an average age of 62 years and in
which 50 % of the participants were female. In the ARIC
study [27], with a follow-up of 10.3 years, the incidence
was 13.9 per 1000 individuals-year, probably due to the
study being carried out in a diabetic population. In the
Cardiovascular Health study [16] the incidence was 15.8
per 1000 individuals-year, which may potentially be ex-
plained by the increased age of the participants, almost
10 years older (74.8 ± 4.8) than in our study. However,
the highest prevalence (44 per 1000 individuals-year)
was found in the BARI 2D study [19] carried out with
diabetic subjects with stable coronary heart disease.
On the other hand, the mean ABI of this study (1.099)
was similar to that in other studies. Lahoz et al [13] re-
ported a mean ABI of 1.07, similar to that found in the
Cardiovascular Health Study [16] despite the partici-
pants being older than in our study. In the Edinburg
Health Study [26], including subjects between the ages
of 55–74, the mean ABI was 1.08. In the MESA study
[28, 29] the mean ABI was 1.11, in a population in which
the mean age was similar to that of our study (61 vs
63 years of age).
With regard to the decrease in ABI values along the
follow up period, a wide variability is described in the
different studies published to date probably due to the
inclusion of participants with and without PAD. Lahoz
et al [13] (750 volunteers) found a decrease in ABI
Table 1 Baseline characteristics of the sample, according to incidence of peripheral artery disease (PAD) (Continued)
Ankle SBP (minimum of both legs) (mmHg) (mean, SD) 147 21 144 24 147 21 0.124
Control brachial SBP (mmHg) (mean, SD) 135 18 142 20 135 18 0.000
Ankle-brachial index (minimum of both legs) (mean, SD) 1.10 0.10 1.01 0.09 1.09 0.10 0.000
SD standard deviation, SBP systolic blood pressure
aMissing values (without PAD + with PAD): education level (101 + 4), physical activity in leisure time (424 + 20), physical activity limitations (19 + 1), body mass
index (2 + 0), central obesity (11 + 0), hypertension (28 + 3), hypercholesterolemia (51 + 1), LDL (20 + 0), triglycerides (22 + 0), atherogenic dyslipidaemia (1 + 0),
Framingham and REGICOR scores (17 + 0)
bExpressed in thousands of METS spent in 14 days doing sporting activities, walking, gardening, walking up stairs, housecleaning and shopping by foot
cCentral obesity if the circumference of the hip ≥102 (men) or ≥88 (women)
dREGICOR and Framingham scores are calculated only in those under 74 years of age at recruitment (n = 2035 under 74 years of age)
Table 2 Incidence of peripheral artery disease (PAD)
Overall Men Women
Cases Ia CI 95 % Cases Ia CI 95 % Cases Ia CI 95 %
PAD 95 8.6 6.9–10.5 46 10.2 7.4–13.5 49 7.5 5.5–9.9
Symptomatic PADb 18 1.6 1.0–2.6 11 2.4 1.2–4.3 7 1.1 0.4–2.2
Assymptomatic PADb 71 6.4 5.0–8.1 34 7.5 5.2–10.5 37 5.6 4.0–7.8
aIncidence per 1000person-year
b2 patients with PAD without information on intermittent claudication and 4 that cannot walk
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after 4 years of 0.02 ± 0.12 points and in the Edinburg
Artery Study [26] (695 participants), there was a de-
crease in ABI values of 0.01 points across the 12 years
of follow-up. The 6-year Cardiovascular Health follow-
up study [16] (2071 participants), described differences
in ABI in subjects with PAD (decrease of 0.33 ± 0.12)
compared to healthy subjects (0.02 ± 0.13), being
values similar to those found in our study with a de-
crease of 0.22 ± 0.13 and an increase of 0.02 ± 0.13,
respectively.
Table 3 Risk factors associated with peripheral artery disease (PAD). Analysis adjusted by age, gender and baseline ankle-brachial
index (ABI)
Baseline variablesa HR CI 95 % p
Men 1.81 1.20–2.71 0.011
Age (by year) 1.04 1.01–1.06 0.006
Education level
Illiterate 1.00
Primary education 0.71 0.32–1.57 0.288
Secondary education or University 0.85 0.35–2.07 0.385
Smoking habit
Never smoker 1.00
Former smoker 2.69 1.45–5.01 0.002
Current smoker 3.78 2.01–7.11 0.000
Physical activity in leisure timeb (mean, SD) 0.97 0.90–1.05 0.498
Physical activity limitations
None 1.00
Moderate 2.03 1.20–3.42 0.008
Can only do light activities or any activity causes breathlessness 2.55 1.31–4.97 0.006
Body mass index (Kg/m2) (mean, SD) 1.03 0.98–1.07 0.234
Central obesityc 1.10 0.70–1.73 0.690
Morbidity (clinical record)
Hypertension 1.71 1.09–2.67 0.018
Hypercholesterolemia 0.98 0.65–1.47 0.905
Diabetes 1.73 1.06–2.84 0.028
High LDL (>130 mg/dl) 0.89 0.59–1.34 0.577
Low HDL (<40 mg/dl men, <50 mg/dl women) 1.82 1.17–2.82 0.008
High triglycerides (>150 mg/dl) 1.05 0.66–1.65 0.846
Atherogenic dyslipidaemia 1.11 0.58–2.12 0.742
aMissing values (withoutPAD + with PAD): education level (101 + 4), physical activity in leisure time (424 + 20), physical activity limitations (19 + 1), body mass index
(2 + 0), central obesity (11 + 0), hypertension (28 + 3), hypercholesterolemia (51 + 1), LDL (20 + 0), triglycerides (22 + 0), atherogenic dyslipidaemia (1 + 0)
bExpressed in thousands of METS spent in 14 days doing sporting activities, walking, gardening, walking up stairs, housecleaning and shopping by foot
cCentral obesity if the circumference of the hip ≥102 (men) or ≥88 (women)
Table 4 Risk factors associated with peripheral artery disease (PAD). Multivariate analysisa
Baseline variablesb HR CI 95 % p
Age (by year) 1.04 1.01–1.07 0.003
Low HDL (<40 mg/dl men, <50 mg/dl women) 1.68 1.08–2.63 0.023
Moderate limitation of physical activities 1.99 1.18–3.37 0.010
Only light activities or any activity causes breathlessness 2.36 1.21–4.63 0.011
Former smoker 2.49 1.53–4.05 0.000
Current smoker 3.49 2.07–5.90 0.000
aAlso adjusted by baseline ankle-brachial index
b20 subjects with missing values excluded
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Progression of PAD
The results of studies on the progression of PAD and
the criteria used to define progression also vary greatly.
In the present study we found that 15.0 % of the subjects
showed a decrease in ABI values greater than 10 % at
5 years of follow- up, while Lahoz et al [13] found a de-
crease in 21.6 % of the volunteer participants. Kallio et
al [18] reported progression of PAD (decrease of ABI
>15 %) in 19 % of the subjects after 11 years of follow-
up. In the Cardiovascular Health Study [16], PAD pro-
gression was found (decrease of ABI > 15 % or ABI <0.9)
in 9.5 % of the subjects after 6 years of follow-up, being
associated with an increase in morbidity-mortality.
Variables associated with peripheral artery disease
incidence
The risk factors associated with the incidence of PAF in
this study were age, male gender, arterial hypertension,
diabetes and low HDL cholesterol and their presence al-
most doubles the risk of presenting PAD during follow-
up Major physical activity limitations and active smoking
also increased the risk of PAD incidence by 2.5 and 4
times, respectively.
However, obesity, central obesity, hypercholesterol-
emia, high LDL cholesterol and hypertriglyceridemia
were not found to be associated with the incidence of
PAD similar to what has been suggested by other au-
thors [13, 14].
Age is a risk factor associated with the progression of PAD
in most of the studies published to date [10, 15, 16, 30].
This is probably due to the increase in the prevalence of
different risk factors with age, thereby explaining the dis-
appearance of these factors disappear in the multivariate
model adjusted for age. The progression of arteriosclerosis
also advances with age, likely because, as some authors
suggest, of the longer exposure to risk factors over time
[31]. However, in our study we found that in participants
< 65 years of age, the incidence of PAD in men is practic-
ally double that of women. On the other hand, in subjects
over the age of 75 years, the incidence of PAD is much
higher, albeit more equal for both genders.
As in the majority of studies, we found an association be-
tween male gender [13, 15, 19] and the incidence or the
progression of PAD. This may be explained by the in-
creased prevalence of smoking in males or, as suggested by
some authors, due to genetic predisposition. However,
paradoxically, in some studies fewer cardiovascular risk fac-
tors as well as a lower incidence of PAD events and, con-
trarily, an increased predisposition for PAD were found in
women [32].
In general, as described in the literature and as found in
the present study smoking, arterial hypertension and dia-
betes are the most important risk factors associated with
the incidence and progression of PAD [14, 15, 27]. Differ-
ent studies, including ours, have also found an inverse as-
sociation with HDL cholesterol figures [33]. In our study,
only age, smoking, HDL cholesterol and a less-studied
variable, decreased physical activity, remained in the multi-
variate model. On the other hand, despite showing a rela-
tionship with PAD in the non- adjusted models, factors
such as hypertension or diabetes were not included in the
multivariate model. The relatively low number of cases
studied and the correlation with other variables may ex-
plain why these variables were not associated with PAD in
the multivariate model
Strengths and limitations of the study
The strengths of this study include the fact that it was car-
ried out in the general population, used follow-up via tele-
phone and in-person in the second ABI measurement,
Table 5 Risk factors associated with a decrease of 10 % of the ankle-brachial index (ABI). Multivariate logistic regression model
Baseline variablesa OR CI 95 % p
Age (by year) 1.03 1.01–1.04 0.001
Education level
Illiterate 1.00
Primary education 0.52 0.33–0.83 0.005
Secondary education or University 0.65 0.39–1.08 0.097
Smoking habit
Never smoker 1.00
Former smoker 1.42 1.08–1.85 0.011
Current smoker 2.04 1.51–2.75 0.000
Physical activity limitations
None 1.00
Moderate 1.34 1.05–1.72 0.018
Only light activities or any activity causes breathlessness 1.22 0.78–1.90 0.388
a123 subjects with missing values excluded
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was carried out by trained individuals, used standardized
measures for all participants, confirmed clinical risk fac-
tors based on clinical history, had high participation dur-
ing the 5 years of follow-up and performed quality control
of the data analyzed, all of which increase the validity of
the results obtained.
However, although participation at 5 years was high
(77 %), significant differences were found between the par-
ticipating and non-participating patients, as found by other
authors [1]. Older subjects and those with more patholo-
gies were those that did not participate in the second ABI
measurement which may lead to an underestimation of in-
cidence in our study, and may alter the presence of other
risk factors associated with the appearance of PAD. How-
ever, this limitation is inherent in most longitudinal stud-
ies, particularly in those following older individuals. Our
results do not differ greatly from those published previ-
ously; however it does provide more valid information, in
terms of the sample studied, and with results from Spain.
The limited correlation found between the results of the
baseline ABI and those of the follow- up (r = 0.23) is an-
other potential limitation of the study, perhaps because
the ABI was based on a single determination taken at one
specific time. Moreover, inter and intra observer variability
could affect this correlation. This may decrease the reli-
ability of the results, although it is also another common
limitation in all studies. To improve this, it may be more
appropriate to determine the ABI on three occasions, sep-
arated by a reasonable amount of time and obtaining a
result being the mean of the 3 determinations, as done for
the diagnosis of arterial hypertension.
The incidence of PAD, based on an ABI in the second
determination was calculated at the same time that the
measurement was performed. This may lead to an artifi-
cial extension of observation time for the participants
with PAD events, since the event probably occurred at
some point between recruitment and the second ABI
measurement. This may also lead to a slight underesti-
mation of the incidence of PAD, since the time of diag-
nosis is delayed. In any case, this is inevitable and occurs
in most studies on incidence, in which the time disease
diagnosis does not coincide with the actual appearance
of the disease in the patient.
Conclusions
The incidence of PAD in the ARTPER cohort is 8.6 cases
per 1000 individuals-year, being higher in men than in
women, particularly in those under the age of 65. Smoking,
age and physical activity limitations are the factors that are
the most frequently associated with a decrease in ABI and
the appearance of PAD. The correlation between 2 ABI
measurements, separated by 5 years of follow-up is low;
therefore it may be necessary to examine whether repeated
measures of the ABI might improve this correlation.
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